4.76

5.08% 0.23

Cumberland Pharmaceuticals Inc (CPIX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Cumberland Pharmaceuticals Inc stock is traded at $4.76, with a volume of 25,487. It is up +5.08% in the last 24 hours and down -7.93% over the past month. Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Previous Close:

$4.53

Open:

$4.55

24h Volume:

25,487

Relative Volume:

0.02

Market Cap:

$58.53M

Revenue:

$37.79M

Net Income/Loss:

$-10.38M

P/E Ratio:

-6.5205

EPS:

-0.73

Net Cash Flow:

$-1.00M

1W Performance:

+18.11%

1M Performance:

-7.93%

6M Performance:

+271.87%

1Y Performance:

+203.18%

1-Day Range:

$4.4709

$4.78

1-Week Range:

$3.92

$4.78

52-Week Range:

$1.04

$7.25

Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile

Name

Cumberland Pharmaceuticals Inc

Sector

Healthcare (1151)

Industry

Drug Manufacturers - Specialty & Generic (1)

Phone

615-255-0068

Address

2525 WEST END AVENUE, NASHVILLE,, TN

Employee

Twitter

Next Earnings Date

2025-03-04

Latest SEC Filings

CPIX's Discussions on Twitter

Compare CPIX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CPIX Cumberland Pharmaceuticals Inc	4.76	58.53M	37.79M	-10.38M	-1.00M	-0.73
ZTS Zoetis Inc	148.67	67.28B	9.26B	2.49B	2.30B	5.47
HLN Haleon Plc Adr	10.22	45.62B	14.35B	1.85B	0	0.4023
TAK Takeda Pharmaceutical Co Adr	14.71	45.01B	30.25B	1.37B	5.08B	0.4257
TEVA Teva Pharmaceutical Industries Ltd Adr	13.65	15.60B	16.54B	-1.64B	749.00M	-1.45
UTHR United Therapeutics Corp	284.73	12.77B	2.76B	1.11B	898.10M	22.77

Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-12-12	Reiterated	UBS	Neutral
Feb-01-11	Reiterated	UBS	Neutral
Dec-16-10	Downgrade	UBS	Buy → Neutral
Aug-17-10	Downgrade	Jefferies	Buy → Hold
Aug-17-10	Reiterated	Morgan Joseph	Buy
Aug-17-10	Reiterated	UBS	Buy
May-14-10	Reiterated	Morgan Joseph	Buy

View All

Cumberland Pharmaceuticals Inc Stock (CPIX) Latest News

Apr 18, 2025

Cumberland Pharmaceuticals' (NASDAQ:CPIX) growing losses don't faze investors as the stock swells 18% this past week - simplywall.st

Apr 18, 2025

Apr 10, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Crosses Above 200 Day Moving Average – Here’s Why - Defense World

Apr 10, 2025

Apr 06, 2025

Cumberland Pharmaceuticals director Caroline Young acquires $383 in common stock - Investing.com Australia

Apr 06, 2025

Apr 05, 2025

Cumberland Pharmaceuticals director Kenneth Krogulski acquires $4,548 in stock By Investing.com - Investing.com South Africa

Apr 05, 2025

Cumberland Pharmaceuticals director James Jones buys shares worth $880 By Investing.com - Investing.com South Africa

Apr 05, 2025

Apr 04, 2025

Cumberland Pharmaceuticals director Kenneth Krogulski acquires $4,548 in stock - Investing.com

Apr 04, 2025

Cumberland Pharmaceuticals CEO A.J. Kazimi acquires $880 in common stock - Investing.com

Apr 04, 2025

Cumberland Pharmaceuticals director James Jones buys shares worth $880 - Investing.com India

Apr 04, 2025

Mar 25, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Price Passes Above 200 Day Moving Average – What’s Next? - Defense World

Mar 25, 2025

Mar 21, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Mar 21, 2025

Mar 19, 2025

FIGHT DMD trial results selected for late-breaking presentation at MDA clinical & scientific conference - Marketscreener.com

Mar 19, 2025

Breakthrough DMD Heart Disease Treatment Achieves 5.4% Function Boost While Controls Decline - Stock Titan

Mar 19, 2025

Mar 12, 2025

Burn Pain Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Cumberland Pharma, Janssen R&D, Cephalon - The Globe and Mail

Mar 12, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200-Day Moving Average – Here’s Why - Defense World

Mar 12, 2025

Mar 10, 2025

Earnings call transcript: Cumberland Q4 2024 results show revenue rise By Investing.com - Investing.com Australia

Mar 10, 2025

Mar 09, 2025

CPIX Stock Price and Chart — NASDAQ:CPIX - TradingView

Mar 09, 2025

Mar 08, 2025

Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Rating Upgraded by StockNews.com - Defense World

Mar 08, 2025

Mar 07, 2025